🇺🇸 FDA
Pipeline program

KSV01 Injection

KSV01-R101

Phase 1 small_molecule active

Quick answer

KSV01 Injection for Non-Hodgkin Lymphoma is a Phase 1 program (small_molecule) at TScan Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
TScan Therapeutics
Indication
Non-Hodgkin Lymphoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials